id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-D-0305-0058,FDA,FDA-2011-D-0305,Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Guidance for Industry and Food and Drug Administration Staff; Availability,Notice,Notice of Availability,2013-11-25T05:00:00Z,2013,11,2013-11-25T05:00:00Z,,2013-11-26T13:37:08Z,2013-28084,0,0,0900006481495921
FDA-2011-D-0305-0057,FDA,FDA-2011-D-0305,"Hyman, Phelps & McNamara, P.C. - Supplement Comment re FDA-2011-D-0305-0050",Other,Supplemental Comment,2012-03-20T04:00:00Z,2012,3,2012-03-20T04:00:00Z,,2012-03-20T21:09:26Z,,0,0,0900006480fb95ae
FDA-2011-D-0305-0001,FDA,FDA-2011-D-0305,Draft Guidance for Industry and FDA Staff: Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions; Availability,Notice,NAD-Notice of Availability of Data,2011-06-01T04:00:00Z,2011,6,2011-06-01T04:00:00Z,2011-08-31T03:59:59Z,2011-06-01T20:42:07Z,2011-13390,0,0,0900006480e38c85
FDA-2011-D-0305-0002,FDA,FDA-2011-D-0305,Commercially Distributed In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Frequently Asked Questions - Draft Guidance,Other,GDL-Guidance (Supporting and Related Materials),2011-06-01T04:00:00Z,2011,6,2011-06-01T04:00:00Z,,2024-11-07T22:31:34Z,,1,0,0900006480e3906e